Abstract:Inflammatory bowel disease (IBD) increases the risk of colorectal cancer, and it has the potential to diminish the quality of life. Clinical and experimental evidence demonstrate protective aspects of parasitic helminth infection against IBD. However, studies on the inhibition of inflammation by helminth infection have overlooked a key determinant of health: the gut microbiota. Although infection with helminths induces alterations in the host microbiota composition, the potential influence and mechanism of helminth infections induced changes in the gut microbiota on the development of IBD has not yet been elucidated. In this study, we analyzed the intersection of helminth Trichinella spiralis and gut bacteria in the regulation of colitis and related mechanisms. T . spiralis infected mice were treated with antibiotics or cohoused with wild type mice, then challenged with dextran sodium sulfate (DSS)-colitis and disease severity, immune responses and goblet cells assessed. Gut bacteria composition was assessed by 16S rRNA sequencing and short-chain fatty acids (SCFAs) were measured. We found that protection against disease by infection with T . spiralis was abrogated by antibiotic treatment, and cohousing with T . spiralis - infected mice suppressed DSS-colitis in wild type mice. Bacterial community profiling revealed an increase in the abundance of the bacterial genus Muribaculum and unclassified_Muribaculaceae in mice with T . spiralis infection or mice cohoused with T . spiralis - infected mice. Metabolomic analysis demonstrated significantly increased propionic acid in feces from T . spiralis - infected mice. Data also showed that the gut microbiome modulated by T . spiralis exhibited enhanced goblet cell differentiation and elevated IL-10 levels in mice. These findings identify the gut microbiome as a critical component of the anti- colitic effect of T . spiralis and gives beneficial insights into the processes by which helminth alleviates colitis. IBD encompasses Crohn's Disease and Ulcerative Colitis. It affects both children and adults. Reports have highlighted the potential use of helminths or their byproducts as a possible treatment for IBD. Accumulating evidence also suggests that the gut microbiota is a key factor in modulating IBD. In this study, we revealed the protective effect of a prior infection with T . spiralis on DSS- induced colitis in mice. Specifically, T . spiralis infection reshaped the gut microbiome of mice, resulting in an increased abundance of SCFA-producing bacteria Muribaculum and unclassified_Muribaculaceae and thereby producing a larger amount of propionic acid. Furthermore, the gut microbiome modulated by T . spiralis exhibited enhanced goblet cell differentiation and elevated IL-10 levels, ultimately ameliorating experimental colitis. These findings suggest that the modulation of host microbiota during T . spiralis infection plays a crucial role in the suppression of colitis, and any intention-to-treat with helminth therapy should be based on the patient's immunological and microbiological response to the helminth.

S4737 Coexistence of Intestinal Spirochetosis and Colorectal Cancer: Could the Coil Be Carcinogenic?

Factors and presenting symptoms associated with intestinal spirochaetosis in men who have sex with men: A systematic review

Colorectal cancer in inflammatory bowel disease: review of the evidence

Intestinal helminth infection drives carcinogenesis in colitis-associated colon cancer

Oral Bacteria and Intestinal Dysbiosis in Colorectal Cancer

Increased levels of anti- Encephalitozoon intestinalis antibodies in patients with colorectal cancer

S2799 Simultaneous Clostridioides difficile Infection, Ulcerative Colitis and Colon Adenocarcinoma – Cause or Effect?

Colorectal Cancer In Inflammatory Bowel Disease: Epidemiology, Pathogenesis And Surveillance

Exploring the relationship between ulcerative colitis, colorectal cancer, and prostate cancer

Ulcerative Colitis-Induced Colorectal Carcinoma: A Deleterious Concatenation

Inflammation and colorectal cancer: colitis-associated neoplasia

Dysplasia and colorectal cancer in inflammatory bowel disease: a result of inflammation or an intrinsic risk?

Ulcerative colitis and colon cancer: Biology and surveillance

The gut microbiota is essential for Trichinella spiralis —Evoked suppression of colitis

Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes

Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management

Gut Dysbiosis and Abnormal Bile Acid Metabolism in Colitis-Associated Cancer

Microbial Dysbiosis in Colorectal Cancer (CRC) Patients

Prevalence and implications of pKs-positive Escherichia coli in colorectal cancer

Gut microbiota, inflammatory bowel disease and colorectal cancer

The Role of Dicrocoelium dendriticum Egg Antigen in Colitis: A Molecular, Pathological and Serological Study in an Experimental Model of C57BL/6 Mice